SCHEMBL26125895

SCHEMBL26125895

N#Cc1c(N)c2ccc(C(F)(F)F)cc2n(-c2ccccc2)c1=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAT2A P31153 3/20 0.48
▸ CTSK P43235 4/20 0.45
▸ ALDH1A1 P00352 4/20 0.42
▸ POLB P06746 1/20 0.42
▸ G6PD P11413 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ TDP2 O95551 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ KIF11 P52732 1/20 0.37
▸ PIK3CD O00329 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PIK3R1 P27986 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30608124 1.00 MAT2A (0.48) MAT2ACTSKALDH1A1POLBG6PD
SCHEMBL30358964 0.86 MAT2A (0.48) MAT2ACTSKALDH1A1POLBG6PD
SCHEMBL28978826 0.86 MAT2A (0.48) MAT2ACTSKALDH1A1POLBG6PD
SCHEMBL28978808 0.86 MAT2A (0.48) MAT2ACTSKALDH1A1POLBG6PD
SCHEMBL29417542 0.86 MAT2A (0.48) MAT2ACTSKALDH1A1POLBG6PD
SCHEMBL30608064 0.81 ALDH1A1 (0.45) MAT2AALDH1A1POLBG6PDHPGD
SCHEMBL30608067 0.81 HPGD (0.54) MAT2AALDH1A1POLBHPGDCYP1A2
SCHEMBL26127178 0.81 ALDH1A1 (0.45) MAT2AALDH1A1POLBG6PDHPGD
SCHEMBL30608069 0.81 MAPK8 (0.49) MAT2AALDH1A1POLBHPGDCYP1A2
SCHEMBL26125920 0.81 MAPK8 (0.49) MAT2AALDH1A1POLBHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116924983-A Novel heterocyclic compound 首药控股(北京)股份有限公司 2023-10-24 — — CN disclosed
WO-2023185811-A1 NOVEL HETEROCYCLIC COMPOUND 首药控股(北京)股份有限公司 2023-10-05 — — WO disclosed
Send feedback